• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Adderall shortage: Exploring first-time Adderall prescriptions and fill rates

Adderall shortage: Exploring first-time Adderall prescriptions and fill rates

by Truveta Research | Dec 14, 2024 | Research, Research Insights

First-time amphetamine/dextroamphetamine prescription rates remained stable overall, but increased significantly for people 30-44, 45-64, and 65+ years of age. The percentage of prescriptions filled within 5 days of being written reached their lowest values in March...
Adderall shortage: Exploring first-time ADHD diagnosis rates

Adderall shortage: Exploring first-time ADHD diagnosis rates

by Truveta Research | Dec 11, 2024 | Research, Research Insights

The rate of first-time ADHD diagnoses has increased since 2021. The largest increases in first-time ADHD diagnosis rates were seen in the 30-44-year-old and 45-64-year-old age groups. Age groups under 30 years old did not see increases in first-time ADHD diagnosis...
Truveta Data used in new study exploring trends in colorectal cancer screening

Truveta Data used in new study exploring trends in colorectal cancer screening

by Truveta staff | Nov 4, 2024 | Research

Citation: Shaukat, Aasma MD, MPH et al. Real-World Adherence to Repeat Testing for Stool-Based Non-Invasive Colorectal Cancer Screening Tests Among Individuals With Average Risk. The American Journal of Gastroenterology 119(10S):p S265-S266, October...
Real-time monitoring of respiratory virus-associated hospitalizations: Trends through early October 2024

Real-time monitoring of respiratory virus-associated hospitalizations: Trends through early October 2024

by Truveta staff | Oct 28, 2024 | Research

Overall, the rate of hospitalizations associated with respiratory viruses decreased throughout September 2024 and into the first week of October. For infants and children aged 0-4 years old, respiratory virus-associated hospitalizations increased slightly by 2.9%...
Truveta recognized on national and Seattle LinkedIn Top Startup 2024 lists

Truveta recognized on national and Seattle LinkedIn Top Startup 2024 lists

by Truveta News | Oct 9, 2024 | News

Today, Truveta was featured as #3 on LinkedIn’s inaugural Top Startups in Seattle list. The ranking highlights ten growing start-up companies in the Seattle area.   Last month, Truveta was also included on the national LinkedIn’s Top Startups list for 2024, which...
« Older Entries
Next Entries »

Share this


Recent posts

  • New study finds GLP-1 RA medications may significantly reduce risk of alcohol-related hospitalization
  • Understanding the impact of the COVID-19 pandemic on childhood MMR vaccination patterns
  • Shifting trends in TKA fixation: Real-world evidence on the changing landscape of cemented vs uncemented TKA

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice